Last reviewed · How we verify

Coagulation assay

Assistance Publique - Hôpitaux de Paris · Phase 2 active Biologic

A coagulation assay is a diagnostic test that measures blood clotting function and identifies coagulation disorders.

A coagulation assay is a diagnostic test that measures blood clotting function and identifies coagulation disorders. Used for Diagnosis and monitoring of coagulation disorders, Assessment of bleeding risk prior to surgery, Monitoring of anticoagulant therapy.

At a glance

Generic nameCoagulation assay
SponsorAssistance Publique - Hôpitaux de Paris
ModalityBiologic
Therapeutic areaDiagnostics / Hematology
PhasePhase 2

Mechanism of action

Coagulation assays evaluate the intrinsic, extrinsic, and common pathways of the coagulation cascade by measuring prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), and platelet count. These tests help diagnose bleeding disorders, monitor anticoagulant therapy, and assess thrombotic risk in clinical settings.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: